What aspects of the health technology assessment process recommended by international health technology assessment agencies received the most attention in Poland in 2008?
OBJECTIVE
The primary objective of this study was to determine the extent to which international standards on transparency and quality are met by the health technology assessment (HTA) process in Poland. A secondary objective is to describe the outcomes of the HTA process and their associated factors.


METHODS
All published online HTA appraisal and meeting proceedings on pharmaceutical products in 2008 were reviewed using a score card developed from international checklists recommended by INAHTA and ECHTA.


RESULTS
The sixty-nine reports reviewed showed that five of nine transparency standards and six of eight quality standards were usually met by the HTA reports. Areas for improvement for transparency include inputs from external stakeholders, availability of English summaries, conclusions, implications of results, and suggested program of action. Areas of improvement for quality include appropriateness of target population and comparator/s, sufficiency of evidence on efficacy and safety, methodological rigor, economic model assumptions, and adaptation to the Polish setting. A consideration of the ethical and social consequences to the healthcare system must also be strengthened.


CONCLUSIONS
The study demonstrates that the incorporation and implementation of the HTA appraisal process in Poland has been successful. HTA appraisal reports in Poland have considered most of the international standards of transparency and quality. Recommendations for both HTA users and doers are forwarded for the improvement of the HTA process in the Polish setting.
Warsaw Medical University, Waszaw, Poland. kkolasa@wum.edu.pl
Katarzyna
K
Kolasa
Malgorzata
M
Dziomdziora
Liberty
L
Fajutrao
D030881:Disclosure / Q000592:standards; D038622:Internationality; D004364:Pharmaceutical Preparations; D011044:Poland; D058028:Research Report; D013673:Technology Assessment, Biomedical / Q000592:standards*
D004364:Pharmaceutical Preparations